a16zTaking Bold Bets: NIH and the Future of Biomedical Science
At a glance
WHAT IT’S REALLY ABOUT
NIH’s bold-bet reset: replication, risk-taking, trust, and AI integration
- NIH is launching a $50M Autism Data Science Initiative (13 teams selected from ~250 applicants) aimed at generating clearer answers for families amid rising autism prevalence.
- Bhattacharya highlights emerging clinical signals—leucovorin (folinic acid) helping a subset of autistic children and new evidence linking acetaminophen use in pregnancy to later autism risk—framing both as areas for cautious guidance and further study.
- He argues the “replication crisis” stems from science’s difficulty, specialization, weak incentives to replicate, and peer review/publication standards that mistake publication for truth.
- He advocates importing a Silicon Valley-style portfolio mindset into NIH funding: tolerate productive failure, fund newer ideas, and judge success at the portfolio level rather than per-grant certainty.
- To rebuild trust after pandemic-era overconfidence and inconsistent policies, he calls for “gold-standard science,” humility about uncertainty, academic freedom, and open access publishing—while positioning AI as an augmenting tool that still requires careful validation.
IDEAS WORTH REMEMBERING
5 ideasAutism work is being reframed as a data-science and systems effort.
Bhattacharya describes autism prevalence as high and rising and says NIH lacks actionable causal answers; the new $50M initiative is designed to fund teams capable of integrating datasets and producing clearer, testable hypotheses over the next few years.
Leucovorin is presented as a targeted opportunity, not a universal autism “fix.”
He claims folinic acid can help children with specific folate-processing issues, citing effects like speech restoration in a minority and broader improvement in others, while emphasizing that benefits depend on subtype/biology and should be made more accessible via coverage and guidance.
Pregnancy acetaminophen guidance is moving toward prudence amid contested evidence.
He references newer studies suggesting correlation with later autism diagnoses and supports updated FDA guidance that encourages limited, need-based use (e.g., high fevers) without “panic,” reflecting uncertainty rather than definitive causality.
Replication is treated as the core “truth test” that current incentives underfund.
He argues scientists gain little career reward for replication and negative results often go unpublished; raising standards and funding independent verification would reduce false confidence and improve downstream translation to health benefits.
NIH wants to act more like a portfolio investor—accepting failure to buy breakthroughs.
Bhattacharya contrasts venture portfolios (many failures, a few transformative wins) with NIH’s increasing conservatism, noting funded ideas have aged over decades; he proposes tolerating “productive failure” and enabling publication of what didn’t work and why.
WORDS WORTH SAVING
5 quotesThe standard for truth in science ought to be replication. Independent teams. You don't-- Just don't believe me just 'cause I have an-- I say something is true. You know, other people independently looking at the same thing should arrive at the same answer.
— Dr. Jay Bhattacharya
We should stop punishing scientists who fail. If they fail productively, let them publish in a journal to explain why they're-- what they, what they learned from it. Like, that Silicon Valley spirit, I think, needs to come to science a little bit more.
— Dr. Jay Bhattacharya
The fact that it's published in a journal doesn't mean it's right. It doesn't mean it's true.
— Dr. Jay Bhattacharya
The American people are not stupid. In fact, they're quite smart, and when we talk to them in ways where we show respect for, for their, their, their intelligence with d- with data, allow people to disagree, but then have the evidence right there in front of people, I think people, people will respond with trust, uh, w-where the evidence actually leads.
— Dr. Jay Bhattacharya
It's the individual scientists who believes in their idea, you keeps knocking on the door even when the, the door is closed over and over again until it opens. That's, that's who really makes a big difference in this world.
— Dr. Jay Bhattacharya
High quality AI-generated summary created from speaker-labeled transcript.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome